Ketamine Therapy Clinics in Delaware

Clinics in Delaware most commonly work with patients who have treatment-resistant depression, PTSD, anxiety disorders, OCD, or certain chronic pain conditions. These are the conditions for which ketamine therapy has the most clinical use, though a licensed medical provider needs to assess whether it is appropriate for any individual.

The main cities with listed clinics are Wilmington, Newark, Dover, and Smyrna. Wilmington has the widest range of treatment formats. Dover covers the central part of the state, and Smyrna sits between the two larger metro areas.

Spravato is an FDA-approved nasal spray form of esketamine administered in a clinical setting, with patients monitored on site for a couple of hours after each dose. IV ketamine delivers the drug through an intravenous infusion and is used off-label, which means it is not FDA-approved specifically for psychiatric conditions but is widely used by clinicians for that purpose.

Both formats require an in-person visit to a clinic. Neither is something you take or receive at home.

Based on current listings, IV ketamine infusion does not appear among the clinics in this directory. Spravato and other ketamine formats are what is represented in the state right now. That could change as more clinics are added, so it is worth checking back.

Very few Delaware clinics publish pricing, so calling ahead is the best approach. When you reach out, ask about both the individual session fee and the number of sessions in a typical starter course, since total cost depends on both factors.

Spravato is the format most likely to have some insurance coverage, but whether a specific plan covers it depends on the insurer and the patient's diagnosis. IV ketamine and other off-label formats are generally not covered. Self-pay is the norm for most patients regardless of format.

You will go through an intake and evaluation before any treatment begins. During a session, a clinician or nurse monitors your blood pressure, heart rate, and overall response throughout. For Spravato, you receive the nasal spray and stay at the clinic for an observation period afterward. Other formats vary in length and setup, so ask the specific clinic what to expect.

No. Every listing in this directory is an in-person clinic that administers ketamine treatment at its facility. At-home and telehealth ketamine programs are not included.

Start with treatment format, since not every clinic in Delaware offers the same options. Then look at who provides oversight, what the intake process involves, and how the clinic handles follow-up care. If you are between cities, Smyrna is worth checking because it offers more than one format despite being a smaller community.

Yes. Ketamine is a Schedule III controlled substance under U.S. federal law and is legal for licensed clinicians to prescribe and administer off-label, including for treatment-resistant depression and other conditions. Spravato (esketamine), the FDA-approved nasal-spray form, is dispensed only in certified healthcare settings under a federal Risk Evaluation and Mitigation Strategy (REMS) program. That applies in Delaware as it does nationwide. The standards for who may administer treatment are set by state regulators and by the clinicians themselves; you can look up the current licensing board for your state through the Federation of State Medical Boards directory at fsmb.org. This page is informational and not legal or medical advice. Consult a licensed medical provider before starting treatment.